BACKGROUND: Chagas' cardiomyopathy (CC) is a rising etiology for heart failure (HF) that previously was restricted to some countries of Latin America. The chronic CC cases cause now a profound socio-economic impact. However this issue has not been well studied if compared to other causes of HF. The objective of this study was to assess the cost burden of CC during acute decompensated HF admissions (ADHF), and compare this cost to the other etiologies of HF. METHODS AND RESULTS: By the end of 2006 we started a five year follow-up of 577 consecutive adult patients admitted at a high complexity cardiology university hospital in the city of Sao Paulo, Brazil. This study shows the data of the first admission of each patient of this follow-up. Patients were divided in two groups: CC (58 patients) and non-chagasic (NC) (519 patients). Mortality was different among groups, 19/58 (32.8%) in CC vs 113/519 (21.8%) in NC (p=0.046). The prevalence of signs of inadequate perfusion was higher in the CC group at admission, but in a multivariated analysis chagasic etiology and presence of diabetes were independent predictors of higher costs per day of hospitalization adjusted by mortality. Median costs per day were US$ 308 (277-542) vs US$ 467 (323-815) for NC and CC respectively (p<0.001). CONCLUSION: Treating ADHF patients with CC etiology was more expensive and mortality was higher in this population at the first admission of this follow-up. This could be explained by the severity of Chagas' cardiomyopathy disease.
BACKGROUND:Chagas' cardiomyopathy (CC) is a rising etiology for heart failure (HF) that previously was restricted to some countries of Latin America. The chronic CC cases cause now a profound socio-economic impact. However this issue has not been well studied if compared to other causes of HF. The objective of this study was to assess the cost burden of CC during acute decompensated HF admissions (ADHF), and compare this cost to the other etiologies of HF. METHODS AND RESULTS: By the end of 2006 we started a five year follow-up of 577 consecutive adult patients admitted at a high complexity cardiology university hospital in the city of Sao Paulo, Brazil. This study shows the data of the first admission of each patient of this follow-up. Patients were divided in two groups: CC (58 patients) and non-chagasic (NC) (519 patients). Mortality was different among groups, 19/58 (32.8%) in CC vs 113/519 (21.8%) in NC (p=0.046). The prevalence of signs of inadequate perfusion was higher in the CC group at admission, but in a multivariated analysis chagasic etiology and presence of diabetes were independent predictors of higher costs per day of hospitalization adjusted by mortality. Median costs per day were US$ 308 (277-542) vs US$ 467 (323-815) for NC and CC respectively (p<0.001). CONCLUSION: Treating ADHF patients with CC etiology was more expensive and mortality was higher in this population at the first admission of this follow-up. This could be explained by the severity of Chagas' cardiomyopathy disease.
Authors: Jefferson Luis Vieira; Fábio Rocha Fernandes Távora; Maria Gyslane Vasconcelos Sobral; Glauber Gean Vasconcelos; Germana Porto Linhares Almeida; Juliana Rolim Fernandes; Laura Leite da Escóssia Marinho; Daniel Francisco de Mendonça Trompieri; João David De Souza Neto; Juan Alberto Cosquillo Mejia Journal: Curr Cardiol Rep Date: 2019-02-12 Impact factor: 3.955
Authors: Marcelo Arruda Nakazone; Maurício Nassau Machado; Ana Paula Otaviano; Ana Maria Silveira Rodrigues; Augusto Cardinalli-Neto; Reinaldo Bulgarelli Bestetti Journal: Cardiol Res Pract Date: 2020-07-06 Impact factor: 1.866
Authors: Jefferson L Vieira; Maria G V Sobral; Francisco Y Macedo; Raquel S Florêncio; Germana P L Almeida; Glauber G Vasconcelos; Juliana R Fernandes; Laura L E Marinho; Daniel F M Trompieri; Tilak K R Pasala; Juan A C Mejia; João D Souza-Neto Journal: Transplant Direct Date: 2022-06-24
Authors: Adrián Sánchez-Montalvá; Fernando Salvador; José Rodríguez-Palomares; Elena Sulleiro; Augusto Sao-Avilés; Sílvia Roure; Lluís Valerio; Arturo Evangelista; Israel Molina Journal: PLoS One Date: 2016-06-16 Impact factor: 3.240
Authors: Elizabeth D Brouwer; David Watkins; Zachary Olson; Jane Goett; Rachel Nugent; Carol Levin Journal: BMC Public Health Date: 2015-11-26 Impact factor: 3.295